NICE has backed NHS use of natalizumab, a key treatment option that is safe for use in pregnancy, for more patients with ...

Seven terminally ill people drank the potion that was supposed to end their lives and…woke up? How? Why? When?

Alzheimer’s disease biomarkers measured from finger-prick dried blood samples closely match standard plasma tests and predict ...

Only a handful of the top pharmas have signed Most Favored Nation drug pricing deals with the White House, while smaller ...

Scientists studying Alzheimer’s in African Americans have uncovered a striking genetic clue that may cut across racial lines.

Data indicating unequal treatment effects in women has prompted calls for more nuance in Alzheimer’s diagnosis and drug ...

Denali Therapeutics Inc. DNLI recently outlined its roadmap for 2026 across its portfolio of investigational therapies for ...

Novo Nordisk's long game on weight loss drugs sparks hope in science, but the Street is impatient Novo Nordisk has had a ...

Biogen (BIIB) receives a hold rating as Leqembi sales may begin to sag, although it is possible new drug approvals may make up some of the difference. Eisai's claim that Leqembi delays the progression ...

In early December, the 2025 updates of China’s NRDL were finalised with a total of 114 drugs, including Western drugs and ...

Robbins Geller Rudman & Dowd LLP announces that the Ardent Health class action lawsuit seeks to represent purchasers or acquirers of Ardent Health, Inc. securities between July 18, 2024 and November ...

Telitacicept, a dual inhibitor of the cytokines B-lymphocyte stimulator and a proliferation-inducing ligand, showed efficacy ...